Healthcare IT and Services

TRIMB Healthcare

May 2015

BUYER

Swedish institutional and private investors.

TARGET

Trimb Healthcare holds a portfolio of over-the-counter (OTC) healthcare products treating and preventing conditions such as high cholesterol and blood glucose, red eyes, rhinitis, snoring and nosebleeds. Trimb’s most important product, Betavivo, is an oat-based product which is scientifically proven to reduce cholesterol and blood sugar levels without adverse effects. Betavivo is approved in the EU by EFSA.

TRANSACTION

Convertible issue to existing shareholders and a number of new Swedish institutional and private investors of SEK 55 million to fund further M&A opportunities of OTC products and companies.

Prev Next View all transactions
Cookies

This website is using cookiesfor statistics and user experience

This website uses cookies to improve your user experience, to provide a basis for improvement and further development of the website and to be able to direct more relevant offers to you.

Feel free to read ours privacy policy. If you agree to our use, choose Accept all. If you want to change your choice afterwards, you will find that option at the bottom of the page.